Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Aug;33(2):389–394. doi: 10.1128/iai.33.2.389-394.1981

Lack of greater seroconversion of rhesus monkeys after subcutaneous inoculation of dengue type 2 live-virus vaccine combined with infection-enhancing antibodies.

E N Kraiselburd, J A Lavergne, J P Woodall, M J Kessler, G Meier, J Chiriboga, C G Moore, G E Sather, A Pomales, E Maldonado, R Rivera
PMCID: PMC350710  PMID: 7024129

Abstract

Four groups of six nonimmune male rhesus monkeys were inoculated subcutaneously with formulations of dengue type 2 vaccine virus DEN-2/S-1. Group A received 1.9 x 10(4) plaque-forming units of vaccine in normal human serum albumin diluent. Group B received the same dose combined with a dengue type 2-immune human serum diluted 1:1,600, beyond its neutralization endpoint of 1:300, but having an immune enhancement titer of 250,000. Groups C and D received 10-fold dilutions of these respective formulations. No migration-inhibitory factor was found when peripheral blood mononuclear leukocytes obtained on day 68 post-immunization from monkeys of all experimental groups were tested. No viremia was detected in any of the monkeys when sera taken on postvaccination days 1 through 12 were inoculated into adult Toxorhynchites amboinensis mosquitoes and LLC-MK2 cells. By day 89, four of the six monkeys had seroconverted by the neutralization test in each of groups A, B, and C, and three of five monkeys in group D (one monkey died from cardiac collapse after anesthesia) had seroconverted. Immune enhancement of dengue virus infection is known to occur in humans and monkeys circulating heterologous flavivirus antibodies. In this study, there was no enhancing effect when antibody was mixed with dengue type 2 vaccine virus and injected subcutaneously.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bancroft W. H., Top F. H., Jr, Eckels K. H., Anderson J. H., Jr, McCown J. M., Russell P. K. Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun. 1981 Feb;31(2):698–703. doi: 10.1128/iai.31.2.698-703.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brandt W. E., McCown J. M., Top F. H., Jr, Bancroft W. H., Russell P. K. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun. 1979 Nov;26(2):534–541. doi: 10.1128/iai.26.2.534-541.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  4. DORRANCE W. R., FRANKEL J. W., GORDON I., PATTERSON P. R., SCHLESINGER R. W., WINTER J. W. Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses. J Immunol. 1956 Nov;77(5):352–364. [PubMed] [Google Scholar]
  5. Eckels K. H., Brandt W. E., Harrison V. R., McCown J. M., Russell P. K. Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun. 1976 Nov;14(5):1221–1227. doi: 10.1128/iai.14.5.1221-1227.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eckels K. H., Harrison V. R., Summers P. L., Russell P. K. Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun. 1980 Jan;27(1):175–180. doi: 10.1128/iai.27.1.175-180.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HOTTA S. Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis. 1952 Jan-Feb;90(1):1–9. doi: 10.1093/infdis/90.1.1. [DOI] [PubMed] [Google Scholar]
  8. Halstead S. B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979 Oct;140(4):527–533. doi: 10.1093/infdis/140.4.527. [DOI] [PubMed] [Google Scholar]
  9. Halstead S. B., O'Rourke E. J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 1977 Feb 24;265(5596):739–741. doi: 10.1038/265739a0. [DOI] [PubMed] [Google Scholar]
  10. Halstead S. B., O'Rourke E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977 Jul 1;146(1):201–217. doi: 10.1084/jem.146.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Halstead S. B., Porterfield J. S., O'Rourke E. J. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. 1980 Jul;29(4):638–642. doi: 10.4269/ajtmh.1980.29.638. [DOI] [PubMed] [Google Scholar]
  12. Harrison V. R., Eckels K. H., Sagartz J. W., Russell P. K. Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun. 1977 Oct;18(1):151–156. doi: 10.1128/iai.18.1.151-156.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kuberski T. T., Rosen L. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Am J Trop Med Hyg. 1977 May;26(3):533–537. doi: 10.4269/ajtmh.1977.26.533. [DOI] [PubMed] [Google Scholar]
  14. Lavergne J. A., Harrington J. T. In vitro assessment of delayed hypersensitivity in the human. Inhibition of cell migration from agarose microdroplets. J Immunol Methods. 1978;22(1-2):111–121. doi: 10.1016/0022-1759(78)90063-7. [DOI] [PubMed] [Google Scholar]
  15. Nagarkatti P. S., D'Souza M. B., Rao K. M. Evidence for the in vitro production of migration inhibition factor by sensitized mouse spleen cells stimulated with dengue virus. Indian J Exp Biol. 1978 Jan;16(1):10–12. [PubMed] [Google Scholar]
  16. Russell P. K., Nisalak A., Sukhavachana P., Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967 Aug;99(2):285–290. [PubMed] [Google Scholar]
  17. STOKES J., Jr, WEIBEL R., HALENDA R., REILLY C. M., HILLEMAN M. R. Studies of live attenuated measles virus vaccine in man. I. Clinical aspects. Am J Public Health Nations Health. 1962 Feb;52(2):29–43. doi: 10.2105/ajph.52.suppl_2.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sabin A. B., Schlesinger R. W. PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science. 1945 Jun 22;101(2634):640–642. doi: 10.1126/science.101.2634.640. [DOI] [PubMed] [Google Scholar]
  19. Scott R. M., Nisalak A., Cheamudon U., Seridhoranakul S., Nimmannitya S. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis. 1980 Jan;141(1):1–6. doi: 10.1093/infdis/141.1.1. [DOI] [PubMed] [Google Scholar]
  20. Scott R. M., Nisalak A., Eckels K. H., Tingpalapong M., Harrison V. R., Gould D. J., Chapple F. E., Russell P. K. Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect Immun. 1980 Jan;27(1):181–186. doi: 10.1128/iai.27.1.181-186.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES